SeekPeptides members access detailed tracking tools and protocol guides that help evaluate whether any peptide therapy is producing meaningful results, including frameworks for deciding when to adjust, switch, or escalate treatment approaches
There are also new drugs that preferentially target D3 over D2 (Nakajima et al., 2013), but many patients are refractory to all current treatments, and there is still considerable morbidity and mortality in this population
LiverMuscle Axis: Rebuild insulin sensitivity and mitochondrial efficiency how effectively your cells turn food into usable energy
Early studies indicate a potential role in slowing cognitive decline in Alzheimers and Parkinsons disease
Individuals should be insulin nave and should receive stable dose(s) of any of the following oral non-insulin glucose-lowering medications: metformin, dipeptidyl peptidase 4 (DPP4) inhibitors, sodium-glucose cotransporter 2 inhibitors, and/or alpha-glucosidase inhibitors